View : 50 Download: 0
Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure-activity relationship studies
- Linear diarylheptanoids as potential anticancer therapeutics: synthesis, biological evaluation, and structure-activity relationship studies
- Rahman, A. F. M. Motiur; Lu, Yang; Lee, Hwa-Jong; Jo, Hyunji; Yin, Wencui; Alam, Mohammad Sayed; Cha, Hyochang; Kadi, Adnan A.; Kwon, Youngjoo; Jahng, Yurngdong
- Ewha Authors
- SCOPUS Author ID
- Issue Date
- Journal Title
- ARCHIVES OF PHARMACAL RESEARCH
- ARCHIVES OF PHARMACAL RESEARCH vol. 41, no. 12, pp. 1131 - 1148
- Linear diarylheptanoids; Topoisomerase-I; Topoisomerase-II; Antiproliferative activity
- PHARMACEUTICAL SOC KOREA
- SCIE; SCOPUS; KCI
- Document Type
- In efforts to develop effective anticancer therapeutics with greater selectivity toward cancerous cell and reduced side-effects, such as emetic effects due to detrimental action of the drug toward the intestinal flora, a series of linear diarylheptanoids (LDHs) were designed and synthesized in 7 steps with good-to-moderate yields. All synthesized compounds were evaluated for their antibacterial, antiproliferative, and topoisomerase-I and -II inhibitory activity. Overall, all compounds showed little to no activity against the bacterial strains tested. Most of the synthesized compounds showed good antiproliferative activity against human breast cancer cell lines (T47D); specifically, the IC50 values of compounds 6a, 6d, 7j, and 7e were 0.09, 0.64, 0.67, and 0.99 M, respectively. Among the tested compounds, 7b inhibited topo-I by 9.3% (camptothecin 68.8%), 7e and 7h inhibited topo-II by 38.4 and 47.4% (etoposide 76.9%), respectively, at the concentration of 100M. These results suggest that a set of promising anticancer agents can be obtained by reducing inhibitory actions on different microbes to provide enhanced selectivity against cancerous cells.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.